AR044909A1 - Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia - Google Patents
Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemiaInfo
- Publication number
- AR044909A1 AR044909A1 ARP040102230A ARP040102230A AR044909A1 AR 044909 A1 AR044909 A1 AR 044909A1 AR P040102230 A ARP040102230 A AR P040102230A AR P040102230 A ARP040102230 A AR P040102230A AR 044909 A1 AR044909 A1 AR 044909A1
- Authority
- AR
- Argentina
- Prior art keywords
- radical
- derivatives
- heterocycloalkyl
- alkynyl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Derivados de tiazolilpiperidina de la fórmula general (1), donde: A representa un radical seleccionado entre los radicales del grupo de fórmulas (2); G representa un enlace o un radical divalente seleccionado entre los grupos de fórmula (3); R1 se selecciona entre hidrógeno y un radical alquilo, alquenilo, alquinilo, cicloalquilo, heterocicloalquilo, arilo, heteroarilo, alquilcarbonilo o alcoxicarbonilo; R2, R2', y R3, que pueden ser iguales o diferentes, se seleccionan, independientemente, entre un átomo de hidrógeno, un radical alquilo, alquenilo, alquinilo, cicloalquilo, heterocicloalquilo, arilo o heteroarilo y un radical -NRR'; o R2 y R3 forman, junto con el átomo de nitrógeno al cual están unidos, un heterociclo; R4 y R5, que pueden ser iguales o diferentes, se seleccionan, independientemente, entre un átomo de hidrógeno, un radical alquilo, alquenilo, alquinilo, cicloalquilo, heterocicloalquilo, arilo o heteroarilo y un radical -NRR'; R y R', que pueden ser iguales o diferentes, representan, independientemente entre sí, un átomo de hidrógeno o un radical seleccionado entre alquilo, alquenilo, alquinilo, cicloalquilo, heterocicloalquilo, arilo y heteroarilo; o forman, junto con el átomo de nitrógeno al cual están unidos, un heterociclo, o forman juntos el enlace doble de un radical alquen-1-ilo; Y representa un átomo de oxígeno o azufre; y Z representa -NH- o un átomo de oxígeno; los posibles isómeros geométricos y/u ópticos, epímeros y diversas formas tautoméricas, y posibles formas oxidadas, en especial óxidos de amina, de los mismos, los solvatos y los hidratos de estos compuestos; y también las posibles sales aceptables para uso farmacéutico de los mismos con un ácido o una base, o las prodrogas aceptables para uso farmacéutico de estos compuestos. Los compuestos de la fórmula (1) se aplican en el tratamiento de hipertrigliceridemia, hipercolesterolemia y dislipidemia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0307670A FR2856685B1 (fr) | 2003-06-25 | 2003-06-25 | Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
AR044909A1 true AR044909A1 (es) | 2005-10-05 |
Family
ID=33515396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102230A AR044909A1 (es) | 2003-06-25 | 2004-06-25 | Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia |
Country Status (18)
Country | Link |
---|---|
US (1) | US7674803B2 (es) |
EP (1) | EP1636218B1 (es) |
JP (1) | JP4629666B2 (es) |
KR (1) | KR20060024812A (es) |
CN (1) | CN1809560A (es) |
AR (1) | AR044909A1 (es) |
AT (1) | ATE426599T1 (es) |
AU (1) | AU2004253649B2 (es) |
BR (1) | BRPI0411721A (es) |
CA (1) | CA2531011C (es) |
DE (1) | DE602004020223D1 (es) |
ES (1) | ES2323463T3 (es) |
FR (1) | FR2856685B1 (es) |
MX (1) | MXPA05013521A (es) |
RU (1) | RU2006101890A (es) |
TW (1) | TW200518751A (es) |
WO (1) | WO2005003128A1 (es) |
ZA (1) | ZA200600690B (es) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2865733B1 (fr) * | 2004-02-04 | 2007-10-12 | Merck Sante Sas | Derives de thiazolylimidazole, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en medecine |
EP1637529A1 (en) * | 2004-09-20 | 2006-03-22 | 4Sc Ag | Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
CN101031567B (zh) * | 2004-09-20 | 2011-12-21 | 4Sc股份有限公司 | 新型杂环NF-κB抑制剂 |
US7601745B2 (en) | 2004-09-27 | 2009-10-13 | 4Sc Ag | Heterocyclic NF-kB inhibitors |
US20100267717A1 (en) * | 2005-07-29 | 2010-10-21 | 4Sc Ag | Novel Heterocyclic NF-kB Inhibitors |
MY179032A (en) | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
SG172738A1 (en) * | 2005-07-29 | 2011-07-28 | 4Sc Ag | Novel heterocyclic nf-kb inhibitors |
WO2007020213A2 (en) * | 2005-08-18 | 2007-02-22 | F. Hoffmann-La Roche Ag | Thiazolyl piperidine derivatives useful as h3 receptor modulators |
EP1832586A1 (en) * | 2006-03-10 | 2007-09-12 | Oridis Biomed Forschungs- und Entwicklungs GmbH | Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas |
AU2007224659A1 (en) * | 2006-03-15 | 2007-09-20 | 4Sc Ag | Novel heterocyclic NF-KB inhibitors |
EP1834954A1 (en) * | 2006-03-15 | 2007-09-19 | 4Sc Ag | Thiazoles as NF-kB Inhibitors (proteasome inhibitors) |
WO2007115805A2 (en) * | 2006-04-05 | 2007-10-18 | European Molecular Biology Laboratory (Embl) | Aurora kinase inhibitors |
JP5182088B2 (ja) * | 2006-04-19 | 2013-04-10 | アステラス製薬株式会社 | アゾールカルボキサミド誘導体 |
JP5606734B2 (ja) | 2006-04-25 | 2014-10-15 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
US9090604B2 (en) | 2006-07-27 | 2015-07-28 | E I Du Pont De Nemours And Company | Fungicidal azocyclic amides |
WO2008013622A2 (en) | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
EP2078004B1 (en) * | 2006-10-31 | 2015-02-25 | Merck Sharp & Dohme Corp. | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
AU2007314342B2 (en) * | 2006-10-31 | 2013-02-21 | Merck Sharp & Dohme Corp. | Anilinopiperazine Derivatives and methods of use thereof |
JP5498168B2 (ja) * | 2006-12-01 | 2014-05-21 | ブリストル−マイヤーズ スクイブ カンパニー | アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体 |
PE20081559A1 (es) | 2007-01-12 | 2008-11-20 | Merck & Co Inc | DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA |
ES2531256T3 (es) | 2007-01-25 | 2015-03-12 | Du Pont | Amidas fungicidas |
DE102007047735A1 (de) | 2007-10-05 | 2009-04-09 | Merck Patent Gmbh | Thiazolderivate |
NZ585261A (en) | 2007-10-11 | 2011-10-28 | Astrazeneca Ab | Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors |
TWI428091B (zh) | 2007-10-23 | 2014-03-01 | Du Pont | 殺真菌劑混合物 |
EP2206707B1 (en) | 2007-10-24 | 2014-07-23 | Astellas Pharma Inc. | Azolecarboxamide compound or salt thereof |
CA2703978A1 (en) * | 2007-10-29 | 2009-05-07 | Schering Corporation | Thiazole derivatives as protein kinase inhibitors |
EP2260032A2 (en) * | 2008-01-25 | 2010-12-15 | E. I. du Pont de Nemours and Company | Fungicidal hetercyclic compounds |
AU2009243401A1 (en) | 2008-04-30 | 2009-11-05 | Bayer Cropscience Ag | Thiazol-4-carboxylic acid esters and thioesters as plant protection agents |
BRPI0920767B1 (pt) * | 2008-10-01 | 2018-07-17 | Bayer Intellectual Property Gmbh | tiazóis substituídos por heterociclila como agentes protetores de cultura, seus usos e seus processos de preparação, composições e seu processo de preparação, e método para combate a fungos nocivos fitopatogênicos |
WO2010065579A2 (en) | 2008-12-02 | 2010-06-10 | E. I. Du Pont De Nemours And Company | Fungicidal heterocyclic compounds |
JP5642661B2 (ja) * | 2009-03-05 | 2014-12-17 | 塩野義製薬株式会社 | Npyy5受容体拮抗作用を有するピペリジンおよびピロリジン誘導体 |
EP2272846A1 (de) * | 2009-06-23 | 2011-01-12 | Bayer CropScience AG | Thiazolylpiperidin Derivate als Fungizide |
EP2464643A1 (en) * | 2009-08-12 | 2012-06-20 | Syngenta Participations AG | Microbiocidal heterocycles |
WO2011051243A1 (en) | 2009-10-29 | 2011-05-05 | Bayer Cropscience Ag | Active compound combinations |
JP5827626B2 (ja) | 2009-10-30 | 2015-12-02 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | ヘテロアリールピペリジン及びピペラジン誘導体 |
ES2450424T3 (es) * | 2009-12-22 | 2014-03-24 | Syngenta Participations Ag | Derivados de pirazol |
JP5960683B2 (ja) * | 2010-04-28 | 2016-08-02 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 殺真菌剤としてのケトヘテロアリールピペリジンおよび−ピペラジン誘導体 |
US8598164B2 (en) | 2010-05-06 | 2013-12-03 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
US8815775B2 (en) * | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
BR112013019667B1 (pt) | 2011-02-01 | 2019-07-02 | Bayer Intellectual Property Gmbh | Compostos derivados de heteroaril-piperidina e -piperazina, seus usos, composição, processos de produção de compostos e de composições, método para o controle de fungos fitopatogênicos prejudiciais |
SI2670752T1 (sl) | 2011-02-02 | 2016-10-28 | Vertex Pharmaceuticals Incorporated | Pirolopirazin-spirociklični piperidin amidi kot modulatorji ionskih kanalčkov |
WO2012107477A1 (en) * | 2011-02-10 | 2012-08-16 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
EP2675812B1 (en) * | 2011-02-18 | 2017-08-30 | Vertex Pharmaceuticals Incorporated | Chroman - spirocyclic piperidine amides as modulators of ion channels |
AU2012229187B2 (en) | 2011-03-14 | 2016-11-10 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
BR112013025410A2 (pt) | 2011-04-01 | 2016-12-20 | Astrazeneca Ab | tratamento terapêutico |
PT2785349T (pt) | 2011-11-30 | 2019-12-11 | Astrazeneca Ab | Tratamento combinado de cancro |
AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
WO2015018027A1 (en) | 2013-08-08 | 2015-02-12 | Merck Sharp & Dohme Corp. | Thiazole orexin receptor antagonists |
WO2016086357A1 (en) | 2014-12-02 | 2016-06-09 | Merck Sharp & Dohme Corp. | Methyl oxazole orexin receptor antagonists |
US11760762B2 (en) * | 2017-01-27 | 2023-09-19 | Signalrx Pharmaceuticals, Inc. | Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors |
NZ759001A (en) * | 2017-04-28 | 2023-03-31 | Texas Children’s Hospital | Targeting nanoparticles |
CN111196805A (zh) * | 2018-11-17 | 2020-05-26 | 曲阜德禄生物科技有限公司 | 哌啶基噻唑甲酰胺类化合物合成方法与用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015567A1 (de) * | 1995-10-20 | 1997-05-01 | Dr. Karl Thomae Gmbh | 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung |
US5965537A (en) * | 1997-03-10 | 1999-10-12 | Basf Aktiengesellschaft | Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus |
JP2003529593A (ja) * | 2000-04-04 | 2003-10-07 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 抗菌剤として用いるための2−ヒドロキシムチリンカルバメート誘導体 |
FR2816940A1 (fr) | 2000-11-23 | 2002-05-24 | Lipha | Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation |
GB0129013D0 (en) * | 2001-12-04 | 2002-01-23 | Glaxo Group Ltd | Compounds |
GB0230162D0 (en) * | 2002-12-24 | 2003-02-05 | Metris Therapeutics Ltd | Compounds useful in inhibiting angiogenesis |
-
2003
- 2003-06-25 FR FR0307670A patent/FR2856685B1/fr not_active Expired - Fee Related
-
2004
- 2004-06-02 CA CA2531011A patent/CA2531011C/en not_active Expired - Fee Related
- 2004-06-02 BR BRPI0411721-2A patent/BRPI0411721A/pt not_active IP Right Cessation
- 2004-06-02 EP EP04735742A patent/EP1636218B1/en not_active Expired - Lifetime
- 2004-06-02 MX MXPA05013521A patent/MXPA05013521A/es unknown
- 2004-06-02 RU RU2006101890/04A patent/RU2006101890A/ru unknown
- 2004-06-02 JP JP2006515818A patent/JP4629666B2/ja not_active Expired - Fee Related
- 2004-06-02 DE DE602004020223T patent/DE602004020223D1/de not_active Expired - Lifetime
- 2004-06-02 KR KR1020057024663A patent/KR20060024812A/ko not_active Application Discontinuation
- 2004-06-02 US US10/561,989 patent/US7674803B2/en not_active Expired - Fee Related
- 2004-06-02 ES ES04735742T patent/ES2323463T3/es not_active Expired - Lifetime
- 2004-06-02 AT AT04735742T patent/ATE426599T1/de not_active IP Right Cessation
- 2004-06-02 AU AU2004253649A patent/AU2004253649B2/en not_active Ceased
- 2004-06-02 WO PCT/EP2004/005931 patent/WO2005003128A1/en active Application Filing
- 2004-06-02 CN CNA2004800157394A patent/CN1809560A/zh active Pending
- 2004-06-21 TW TW093117985A patent/TW200518751A/zh unknown
- 2004-06-25 AR ARP040102230A patent/AR044909A1/es unknown
-
2006
- 2006-01-24 ZA ZA200600690A patent/ZA200600690B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20060024812A (ko) | 2006-03-17 |
EP1636218B1 (en) | 2009-03-25 |
TW200518751A (en) | 2005-06-16 |
EP1636218A1 (en) | 2006-03-22 |
JP4629666B2 (ja) | 2011-02-09 |
WO2005003128A1 (en) | 2005-01-13 |
FR2856685A1 (fr) | 2004-12-31 |
DE602004020223D1 (de) | 2009-05-07 |
FR2856685B1 (fr) | 2005-09-23 |
US20070054939A1 (en) | 2007-03-08 |
ZA200600690B (en) | 2007-05-30 |
AU2004253649B2 (en) | 2009-09-24 |
CA2531011A1 (en) | 2005-01-13 |
AU2004253649A1 (en) | 2005-01-13 |
RU2006101890A (ru) | 2007-07-27 |
BRPI0411721A (pt) | 2006-05-23 |
US7674803B2 (en) | 2010-03-09 |
CA2531011C (en) | 2012-10-09 |
MXPA05013521A (es) | 2006-03-09 |
JP2007506651A (ja) | 2007-03-22 |
ES2323463T3 (es) | 2009-07-16 |
CN1809560A (zh) | 2006-07-26 |
ATE426599T1 (de) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR044909A1 (es) | Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia | |
CO5700824A2 (es) | Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen | |
HUP0402313A2 (hu) | Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
AR077267A1 (es) | Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes. | |
AR077598A1 (es) | Compuestos heterociclicos fusionados como modulares de canales ionicos | |
AR037288A1 (es) | Compuestos derivados de sulfonamidas, procedimiento para la obtencion, composicion farmaceutica y uso para la elaboracion de un medicamento | |
AR076264A1 (es) | Triazolopiridinas sustituidas y analogos de estas | |
CY1108313T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
AR037676A1 (es) | Inhibidores del factor xa y de otras proteasas de serina implicadas en la cascada de la coagulacion; composicion farmaceutica que los comprende y procedimiento para preparar compuestos de formula (i) | |
AR036365A1 (es) | 1,8-naftiridin-4(1h)-onas alquin-aril sustituidas y composiciones farmaceuticas que las contienen | |
CY1107301T1 (el) | Ιμιδαζο και θειαζολοπυριδινες ως αναστολεις κινασης jak3 | |
AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
AR069326A1 (es) | Derivados bis-(sulfonilamino), proceso de preparacion, composiciones farmaceuticas que los contienen y su uso en terapia. | |
AR089774A1 (es) | Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR082826A2 (es) | Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos | |
AR050181A1 (es) | Derivados de urea ciclicos sustituidos, su preparacion y su uso farmaceutico como inhibidores de quinasa | |
ECSP067013A (es) | 2-quinolil-oxazoles sustituidos útiles como inhibidores de pde4 | |
AR050963A1 (es) | Derivados bis-azaindolicos, su utilizacion farmaceutica como inhibidores de cinasas y su uso en la fabricacion de medicamentos para el tratamiento de los canceres. | |
AR109931A1 (es) | Compuesto inhibidor de la prostaglandina d sintasa hematopoyética (h-pgds), composición farmacéutica que lo comprende y uso del compuesto para fabricar un medicamento | |
AR033379A1 (es) | Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
AR053340A1 (es) | Derivados de trifluormetilbenzamida y sus usos terapeuticos | |
ES2253568T3 (es) | Compuestos heterociclicos para el uso en el tratamiento de los trastornos de las vias urinarias. | |
AR070263A1 (es) | Derivados de oxazepinopirimidinona arilamido sustituidos, utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, medicamentos que los contienen y proceso de preparacion e intermediarios. | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |